Oxford BioDynamics has announced the admission on Tuesday of its ordinary shares to trading on AIM, a market operated by the London Stock Exchange plc and the beginning of dealings in its Ordinary Shares.
Summary of the Placing
- The Placing, which was oversubscribed, has raised gross proceeds of £20.0 million, of which £7.1 million (before expenses) was allocated to the Company.
- The number of Ordinary Shares in issue on Admission will be 86,098,228, giving the Company a market capitalisation of £136.0 million at the Placing Price of 158 pence per share.
The total number of voting rights in the company with effect from today is 86,098,228 Ordinary Shares. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure and Transparency Rules.